Concepedia

Thomas M. Herndon

TM

Statistics

Publications

7

Citations

880

H-Index

7

Active since

1991

Affiliations

Uniformed Services University of the Health Sciences(Current)

National Institutes of Health

Center for Drug Evaluation and Research

National Heart Lung and Blood Institute

United States Food and Drug Administration

Thomas M. Herndon is an author at Uniformed Services University of the Health Sciences specializing in life sciences, immunology, and medicine.

Publications per year

1991–2017

7

Publications

7

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas et al. · Clinical Cancer Research · 2013 · 241 citations

Medicine, Pharmacology, Pharmacotherapy +17

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

Xingmin Feng, Sachiko Kajigaya, Elena E. Solomou et al. · Blood · 2008 · 238 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood

Thomas M. Herndon, S-S Chen, Nakhle S. Saba et al. · Leukemia · 2017 · 130 citations

Medicine, Cell Biology, Oncology +15

U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma

Thomas M. Herndon, Suzanne Demko, Xiaoping Jiang et al. · The Oncologist · 2012 · 87 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

ZAP-70 and SLP-76 Regulate Protein Kinase C-θ and NF-κB Activation in Response to Engagement of CD3 and CD28

Thomas M. Herndon, Xiaochuan Shan, George C. Tsokos et al. · The Journal of Immunology · 2001 · 76 citations

Life Sciences, Immunology, Molecular Biology +17

1–5 of 7